Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Neoplasm Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592
What this trial is testing

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Who this might be right for
Adrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more
National Cancer Institute (NCI) 109
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Testing effectiveness (Phase 2)Study completedNCT00542048
What this trial is testing

A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases

Who this might be right for
Liver CancerNeoplasm Metastasis
MediGene 20
Not applicableStudy completedNCT02315989
What this trial is testing

Early-Phase Safety of Proton Therapy Equipment

Who this might be right for
Malignant GliomaHepatocellular CarcinomaHead and Neck Malignant Tumor+1 more
Chang Gung Memorial Hospital 6
Not applicableTemporarily pausedNCT04955808
What this trial is testing

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

Who this might be right for
Breast CarcinomaColon CarcinomaInvasive Carcinoma+5 more
National Cancer Institute (NCI) 2,400
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableActive Not RecruitingNCT02892305
What this trial is testing

Hepatic Resection for Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmsNeoplasm MetastasisLiver Metastases
Duke University 18
Not applicableUnknownNCT04111029
What this trial is testing

Liquid Biopsy in Hepatocellular Carcinoma

Who this might be right for
Hepatic Carcinoma Malignant Primary Non-Resectable
Post Graduate Institute of Medical Education and Research, Chandigarh 30
Testing effectiveness (Phase 2)UnknownNCT04033107
What this trial is testing

High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors

Who this might be right for
Hepatocellular CancerPancreatic CancerGastric Cancer+1 more
Zhongnan Hospital 30
Not applicableStudy completedNCT03098589
What this trial is testing

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Who this might be right for
Lymphoma
Celgene 1,149
Not applicableStudy completedNCT03995459
What this trial is testing

Deportalization, Venous Deprivation, Venous Congestion

Who this might be right for
Malignant Liver Tumor
University Hospital, Montpellier 12
Not applicableStudy completedNCT02557724
What this trial is testing

Mobilization of Mesenchymal Stem Cells During Liver Transplantation

Who this might be right for
Liver FailureLiver Neoplasm
Rutgers, The State University of New Jersey 35
Large-scale testing (Phase 3)Ended earlyNCT00023868
What this trial is testing

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

Who this might be right for
Colorectal CancerMetastatic Cancer
American College of Radiology Imaging Network
Not applicableStudy completedNCT00728650
What this trial is testing

A Retrospective Review of Malignant Liver Tumors

Who this might be right for
Liver Cancer
University of Oklahoma 228
Large-scale testing (Phase 3)Study completedNCT00716976
What this trial is testing

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Who this might be right for
Brain TumorCentral Nervous System TumorChildhood Germ Cell Tumor+6 more
Children's Oncology Group 131
Testing effectiveness (Phase 2)Study completedNCT00764595
What this trial is testing

Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal TumorMetastatic Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 5
Not applicableStudy completedNCT02649712
What this trial is testing

Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction

Who this might be right for
CholangiocarcinomaGallbladder CarcinomaHepatocellular Carcinoma
Xuzhou Central Hospital 72
Not applicableLooking for participantsNCT03959800
What this trial is testing

Molecular Basis of Pediatric Liver Cancer

Who this might be right for
Childhood Liver CancerLiver Malignant TumorsEmbryonal Sarcoma of Liver (Disorder)+3 more
University of Pittsburgh 1,600
Testing effectiveness (Phase 2)WithdrawnNCT00408772
What this trial is testing

Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University of California, Davis
Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Next Page